These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6264062)

  • 21. Accumulation of adenosine 3',5'-monophosphate induced by prostaglandin E1 binding to mastocytoma P-815 cells.
    Yatsunami K; Ichikawa A; Tomita K
    Biochem Pharmacol; 1981 Jun; 30(11):1325-32. PubMed ID: 6168266
    [No Abstract]   [Full Text] [Related]  

  • 22. Sensitive determination for adenylate cyclase activity by cyclic adenosine 3',5'-monophosphate protein binding assay.
    Schwabe U; Elbert R; Schönhöfer PS
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 286(1):83-96. PubMed ID: 4375795
    [No Abstract]   [Full Text] [Related]  

  • 23. ATP and cAMP system in the in vitro response of microdissected cortical tubules to PTH.
    Kiebzak GM; Yusufi AN; Kusano E; Braun-Werness J; Dousa TP
    Am J Physiol; 1985 Jan; 248(1 Pt 2):F152-9. PubMed ID: 2982275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aphidicolin: a specific inhibitor of DNA synthesis in synchronous mastocytoma P-815 cells.
    Ichikawa A; Negishi M; Tomita K; Ikegami S
    Jpn J Pharmacol; 1980 Jun; 30(3):301-8. PubMed ID: 6779040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uridine enhances the cytotoxic effect of D-glucosamine in rat C6 glioma cells.
    Calvaruso G; Taibi G; Torregrossa MV; Romano N; Tesoriere G
    Life Sci; 1986 Dec; 39(23):2221-7. PubMed ID: 3784777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic effects of cyclic 9- -D-arabinofuranosyladenine 3',5'-monophosphate in L1210 cells.
    Hughes RG; Kimball AP
    Cancer Res; 1972 Sep; 32(9):1791-4. PubMed ID: 4345037
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of D-glucosamine and 6-azauridine on nucleotide contents, 5-fluorouridine uptake, and cytotoxicity in TA3 mammary tumor cells.
    Holstege A; Keppler D
    J Natl Cancer Inst; 1986 Mar; 76(3):485-92. PubMed ID: 2419623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of growth of P-815 mastocytoma cells in vitro by drugs increasing cellular cyclic 3',5'-adenosine monophosphate.
    Keller R; Keist R
    Life Sci II; 1973 Feb; 12(3):97-105. PubMed ID: 4350667
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of D-glucosamine and D-galactosamine on the uridine nucleotide concentration in mouse myeloid tumor (Graffi) and myeloma MOPC-21.
    Chelibonova-Lorer H
    Neoplasma; 1975; 22(1):23-7. PubMed ID: 1153035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The biochemical and ultrastructural effects of tunicamycin and D-glucosamine in L1210 leukemic cells.
    Morin MJ; Porter CW; McKernan P; Bernacki RJ
    J Cell Physiol; 1983 Feb; 114(2):162-72. PubMed ID: 6822608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA content of mastocytoma cells in cell culture after inhibition of RNA synthesis with 6-azauridine.
    Burki HR
    Cancer Res; 1971 Sep; 31(9):1188-91. PubMed ID: 5000454
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of tunicamycin on functions of PGE1 receptors from mouse mastocytoma P-815 cells.
    Yatsunami K; Fujisawa J; Hashimoto H; Kimura K; Takahashi S; Ichikawa A
    Biochim Biophys Acta; 1990 Jan; 1051(1):94-9. PubMed ID: 2153417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effect of sodium butyrate on cyclic AMP phosphodiesterase activities in butyrate sensitive and resistant mastocytoma cells.
    Mori Y; Tanigaki Y; Yamaguchi A; Akedo H
    Biochem Biophys Res Commun; 1986 Aug; 138(3):1030-6. PubMed ID: 3019329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Taurine and the adenosine cyclic monophosphate levels in the heart].
    Mal'chikova LS; Elizarova EP
    Kardiologiia; 1981 Jan; 21(1):85-9. PubMed ID: 6259404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth inhibition of new human thyroid carcinoma cell lines by activation of adenylate cyclase through the beta-adrenergic receptor.
    Ohta K; Pang XP; Berg L; Hershman JM
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2633-8. PubMed ID: 9253346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycosaminoglycan synthesis in mouse mastocytoma.
    Helting T; Ogren S; Lindahl U; Pertoft H; Laurent T
    Biochem J; 1972 Feb; 126(3):587-92. PubMed ID: 4263037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of cyclic adenosine 3':5'-monophosphate in the action of 1,1,1-trichloro-2,2-bis-(p-chlorophenyl)ethane (DDT)on hepatic and renal metabolism.
    Kacew S; Singhal RL
    Biochem J; 1974 Jul; 142(1):145-52. PubMed ID: 4374184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequential alterations in the hepatic content and metabolism of cyclic AMP and cyclic GMP induced by DL-ethionine: evidence for malignant transformation of liver with a sustained increase in cyclic AMP.
    DeRubertis FR; Craven PA
    Metabolism; 1976 Dec; 25(12):1611-25. PubMed ID: 186692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between adenosine 3',5'-cyclic monosphosphate levels, adenylate cyclase activity, and adenosine 3',5'-cyclic monophosphate phosphodiesterase activity in tissue culture cells stimulated by serum.
    Matsumoto T; Uchida T
    J Biochem; 1975 Oct; 78(4):811-5. PubMed ID: 175046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative study of early effects of epipodophyllotoxin derivatives and other cytostatic agents on mastocytoma cultures.
    Grieder A; Maurer R; Stähelin H
    Cancer Res; 1977 Sep; 37(9):2998-3005. PubMed ID: 69488
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.